Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects

被引:23
作者
Akkermans, Reinier P. [1 ]
Berrevoets, Marvin A. [1 ]
Smeele, Ivo J. [2 ]
Lucas, Annelies E. [3 ]
Thoonen, Bart P. [4 ,5 ]
Grootens-Stekelenburg, Joke G. [1 ]
Heijdra, Yvonne F. [6 ]
van Weel, Chris [1 ]
Schermer, Tjard R. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6500 HB Nijmegen, Netherlands
[2] COPD & Asthma Gen Practitioner Advisory Grp CAHAG, NL-3502 GE Utrecht, Netherlands
[3] Diagnostiek U DCE, NL-5600 HG Eindhoven, Netherlands
[4] Fdn E SHO, Gen Practice Lab, Velp, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6500 HB Nijmegen, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Chest Dis, NL-6500 HB Nijmegen, Netherlands
关键词
Airflow obstruction; Chronic obstructive pulmonary disease; Diagnosis; Lung function decline; Primary care; Spirometry; ABANDON FEV1/FVC LESS-THAN-0.70; PULMONARY-DISEASE; COPD; RATIO; EQUATIONS; DEFINITIONS; PREVALENCE; RISK;
D O I
10.1186/1471-2466-12-12
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Current COPD guidelines advocate a fixed < 0.70 FEV1/FVC cutpoint to define airflow obstruction. We compared rate of lung function decline in respiratory symptomatic 40+ subjects who were 'obstructive' or 'non-obstructive' according to the fixed and/or age and gender specific lower limit of normal (LLN) FEV1/FVC cutpoints. Methods: We studied 3,324 respiratory symptomatic subjects referred to primary care diagnostic centres for spirometry. The cohort was subdivided into four categories based on presence or absence of obstruction according to the fixed and LLN FEV1/FVC cutpoints. Postbronchodilator FEV1 decline served as primary outcome to compare subjects between the respective categories. Results: 918 subjects were obstructive according to the fixed FEV1/FVC cutpoint; 389 (42%) of them were non-obstructive according to the LLN cutpoint. In smokers, postbronchodilator FEV1 decline was 21 (SE 3) ml/year in those non-obstructive according to both cutpoints, 21 (7) ml/year in those obstructive according to the fixed but not according to the LLN cutpoint, and 50 (5) ml/year in those obstructive according to both cutpoints (p = 0.004). Conclusion: This study showed that respiratory symptomatic 40+ smokers and non-smokers who show FEV1/FVC values below the fixed 0.70 cutpoint but above their age/gender specific LLN value did not show accelerated FEV1 decline, in contrast with those showing FEV1/FVC values below their LLN cutpoint.
引用
收藏
页数:14
相关论文
共 35 条
[1]   Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease [J].
Albers, M. ;
Schermer, T. ;
Heijdra, Y. ;
Molema, J. ;
Akkermans, R. ;
van Weel, C. .
THORAX, 2008, 63 (03) :201-207
[2]   THE EFFECT OF PULMONARY IMPAIRMENT ON ALL-CAUSE MORTALITY IN A NATIONAL COHORT [J].
BANG, KM ;
GERGEN, PJ ;
KRAMER, R ;
COHEN, B .
CHEST, 1993, 103 (02) :536-540
[3]  
Brändli O, 2000, THORAX, V55, P173
[4]   International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750
[5]   Outcomes for COPD pharmacological trials:: from lung function to biomarkers [J].
Cazzola, M. ;
MacNee, W. ;
Martinez, F. J. ;
Rabe, K. F. ;
Franciosi, L. G. ;
Barnes, P. J. ;
Brusasco, V. ;
Burge, P. S. ;
Calverley, P. M. A. ;
Celli, B. R. ;
Jones, P. W. ;
Mahler, D. A. ;
Make, B. ;
Miravitlles, M. ;
Page, C. P. ;
Palange, P. ;
Parr, D. ;
Pistolesi, M. ;
Rennard, S. I. ;
Moelken, M. P. Rutten-Van ;
Stockley, R. ;
Sullivan, S. D. ;
Wedzicha, J. A. ;
Wouters, E. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :416-468
[6]   Point: Should We Abandon FEV1/FVC &lt;0.70 To Detect Airway Obstruction? No [J].
Celli, Bartolome R. ;
Halbert, Ron J. .
CHEST, 2010, 138 (05) :1037-1040
[7]   Population impact of different definitions of airway obstruction [J].
Celli, BR ;
Halbert, RJ ;
Isonaka, S ;
Schau, B .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :268-273
[8]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[9]   Underestimation of airflow obstruction among young adults using FEV1/FVC &lt;70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes [J].
Cerveri, I. ;
Corsico, A. G. ;
Accordini, S. ;
Niniano, R. ;
Ansaldo, E. ;
Anto, J. M. ;
Kunzli, N. ;
Janson, C. ;
Sunyer, J. ;
Jarvis, D. ;
Svanes, C. ;
Gislason, T. ;
Heinrich, J. ;
Schouten, J. P. ;
Wjst, M. ;
Burney, P. ;
de Marco, R. .
THORAX, 2008, 63 (12) :1040-1045
[10]   Counterpoint: Should We Abandon FEV1/FVC &lt;0.70 To Detect Airway Obstruction? Yes [J].
Enright, Paul ;
Brusasco, Vito .
CHEST, 2010, 138 (05) :1040-1042